Study of Dietary Patterns and Food Diversity in Russian GERD Patients

February 2, 2022 updated by: Vasily Isakov, Russian Academy of Medical Sciences
The aim of the study is to assess food diversity and dietary patterns in Russian GERD patients

Study Overview

Detailed Description

The study of dietary patterns may provide complex vision of an association between consumption of specific foods, or groups of food products and manifestations of gastroesophageal reflux disease (symptoms: heartburn and acid regurgitation; endoscopic findings - oesophagitis). Only limited data on this matter are published to the moment and they predominantly concerns outcomes of gastroesophageal reflux disease (oesophageal adenocarcinoma or Barrett's oesophagus). Taking into the consideration that earlier studies found significant differences in consumption of nutrients in different world regions, new data on food patterns of dietary patterns in Russian GERD patients could partly fill in the gap of knowledge on this particular matter.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Moscow, Russian Federation, 115446
        • Recruiting
        • Gastroenterology and Hepatology, FRC Nutrition and Biotechnology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • willingness to participate (signed the informed consent form);
  • willingness to follow all the required procedures;

Exclusion Criteria:

  • Pregnant or breast-feeding females;
  • Neoplasms, current or by the medical history (except local skin cancer successfully treated);
  • History of chest or abdominal surgery, except appendectomy and cholecistectomy (in case when no consequences of these operations like adhesive disease of the abdominal cavity are present);
  • Co-morbid conditions which can influence or mask the symptoms of GERD (including, but not limited to: ischaemic heart disease, severe pulmonary disease, severe depression or anxiety, etc);
  • the use of concomitant medications that may influence on the symptoms or other manifestations of gastroesophageal reflux disease: NSAIDs, corticosteroids (except topic ones for no longer than 2 weeks), any medications directly influencing mood and function of central nervous system (antidepressants, anxiolytics, anti-anxiety agents, anticonvulsant etc) at the moment of enrolment and during a 2 half-life period of the certain drug;
  • the use of medications that influence gastric secretion at the time of enrolment and during 2 week before it;
  • any condition of the patient which makes the participation of the patient in the study unreasonable or put him at risk of the condition's exacerbation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: NON_RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: GERD
Patients with verified gastroesophageal reflux disease
Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.
Other Names:
  • Food frequency questionnaire
OTHER: Contol
Mostly healthy subjects who have no symptoms and other manifestations of gastroesophageal reflux disease by complex examination
Dietary assessment is not within standards of care for patients with gastroesophageal reflux disease in Russia. Subjects enrolled to the study are to be interviewed on most common foods consumption in terms of frequency of use and sizes of portions.
Other Names:
  • Food frequency questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
grains consumption diversity
Time Frame: a month
Mean number of different types of grains consumed in form of different foods or food products a month during 12-months period
a month
meat consumption diversity
Time Frame: a month
Mean number of different types of meat consumed in form of different foods or food products a month during 12-months period
a month
poultry consumption diversity
Time Frame: a month
Mean number of different types of poultry consumed in form of different foods or food products a month during 12-months period
a month
fish consumption diversity
Time Frame: a month
Mean number of different types of fish consumed in form of different foods or food products a month during 12-months period
a month
flour consumption diversity
Time Frame: a month
Mean number of different types of flours consumed in form of different foods or food products a month during 12-months period
a month
vegetables consumption diversity
Time Frame: a month
Mean number of different types of vegetables consumed as is or in the form of different foods or food products
a month
Fruits consumption diversity
Time Frame: a month
Mean number of different types of fruits consumed as is or in the form of different foods or food products
a month
Fats consumption diversity
Time Frame: a month
Mean number of different types of fats consumed in the form of different foods or food products a month by 12 month period
a month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GERD-associated dietary pattern
Time Frame: a year
complex of nutrients and/or foods (food products) which correlates with presence of GERD. The correlation coefficients for each food item is range in the order of significance and direction of the relationship and in accordance to the amount of the product consumed, than is formed to the integral mean.
a year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Vasily Isakov, MD, PhD, Professor, AGAF, FRC Nutrition and Biotechnology
  • Principal Investigator: Sergey Morozov, MD, PhD, FRC Nutrition and Biotechnology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 30, 2020

Primary Completion (ANTICIPATED)

September 30, 2023

Study Completion (ANTICIPATED)

December 31, 2023

Study Registration Dates

First Submitted

January 31, 2020

First Submitted That Met QC Criteria

January 31, 2020

First Posted (ACTUAL)

February 5, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 3, 2022

Last Update Submitted That Met QC Criteria

February 2, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study data may be shared by request after study completion, except subjects' personal (identification) information

IPD Sharing Time Frame

After the study completion, available for 2 years

IPD Sharing Access Criteria

By request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastroesophageal Reflux

Clinical Trials on Dietary assessment

3
Subscribe